CERS

CERS Company Financials

$5.48
*  
0.13
  negative  
2.43%
Get CERS Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Annual Income Statement (values in 000's)

Period Ending: Trend 12/31/2012 12/31/2011 12/31/2010 12/31/2009
Total Revenue
$36,786 $33,044 $23,109 $17,982
Cost of Revenue
$20,616 $18,535 $12,046 $12,580
Gross Profit
$16,170 $14,509 $11,063 $5,402
Operating Expenses
Research and Development
$7,603 $7,178 $5,195 $6,372
Sales, General and Admin.
$25,665 $23,053 $21,577 $20,486
Non-Recurring Items
$0 $0 $182 $2,377
Other Operating Items
$202 $202 $67 $0
Operating Income
($17,300) ($15,924) ($15,958) ($23,833)
Add'l income/expense items
$2,176 $49 ($170) ($292)
Earnings Before Interest and Tax
($15,124) ($15,875) ($16,128) ($24,125)
Interest Expense
$551 $964 $689 $10
Earnings Before Tax
($15,675) ($16,839) ($16,817) ($24,135)
Income Tax
$242 $143 $94 $0
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($15,917) ($16,982) ($16,911) ($24,135)
Net Income
($15,917) ($16,982) ($16,911) ($24,135)
Net Income Applicable to Common Shareholders
($15,917) ($16,982) ($16,911) ($24,135)

See also: Company Financials data entry page